cavernous malformation
Recently Published Documents


TOTAL DOCUMENTS

792
(FIVE YEARS 283)

H-INDEX

42
(FIVE YEARS 5)

Cureus ◽  
2022 ◽  
Author(s):  
Martha L Tena Suck ◽  
Juan C Balcázar-Padrón ◽  
Juan P Navarro-Garcia Llano ◽  
Alma Ortíz-Plata ◽  
Juan Luis Gómez-Amador

2022 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Visish M. Srinivasan ◽  
Rohin Singh ◽  
Jakub Godzik ◽  
Joshua S. Catapano ◽  
Michael T. Lawton

2022 ◽  
pp. 189-192
Author(s):  
John M. Stern ◽  
Noriko Salamon

2022 ◽  
pp. 185-188
Author(s):  
John M. Stern ◽  
Noriko Salamon

2021 ◽  
Vol 32 (2) ◽  
pp. 149-155
Author(s):  
João Pedro Einsfeld Britz ◽  
Ildo Sonda ◽  
Renato Luis Calloni ◽  
Yan Bicca ◽  
Arthur Aguzzoli

Cavernous malformations are rare vascular malformations in the central nervous system. We present the case of a 2-month-old female patient who presented tonic-clonic seizures, with no previous history of seizures. Magnetic resonance imaging showed a 5.6 cm tumor in the left parieto-occipital region. The radiological aspect of the tumor initially suggested an anaplastic meningioma. After surgical treatment and anatomopathological analysis, it was found to be a cavernous malformation. Cavernous malformations, or cavernomas, are rare lesions and even more rare is the occurrence of large cavernomas. In the pediatric population, although still quite rare, they usually are presented as larger cavernomas. Surgical resection is considered the most effective treatment.


2021 ◽  
Vol 11 ◽  
Author(s):  
Lei Cao ◽  
Wentao Wu ◽  
Jie Kang ◽  
Hui Qiao ◽  
Xiaocui Yang ◽  
...  

ObjectThe trans lamina terminalis approach (TLTA) has been described as a way to remove third ventricular tumors. The aim of this paper was to analyze the feasible outcomes of TLTA applied to tumors extending into the third ventricle in our institute.MethodsSuprasellar tumors (n = 149) were treated by the extended endonasal approach from September 2019 to December 2020 in Beijing Tiantan Hospital. Eleven of the tumors were treated by TLTA or TLTA via the trans-chiasm-pituitary corridor (TCPC). The surgical technique notes of TLTA were described and indications and outcomes of the approach were analyzed.ResultsThere were 11 patients enrolled in the study, six with papillary craniopharyngiomas, two with adamantinomatous craniopharyngiomas, one with a germinal cell tumor (GCT), one with cavernous malformation and one with chordoid glioma. Four of the patients received a radical resection by TLTA alone, while seven of them received TLTA via the TCPC. Gross total resection was achieved in eight patients (72.7%), and partial resection in three patients (27.3%). Visual function was improved in four of the 11 patients (36.4%), was unchanged in five patients (45.5%), and deteriorated in two patients (18.2%). New-onset hypopituitarism occurred in seven patients (63.3%) and new-onset diabetes insipidus occurred in two patients (18.2%). Electrocyte imbalance were observed in six patients (54.5%) at post-operative week 2. There were no surgery-related deaths or cerebrospinal fluid leaks. Postoperative intracranial infection was observed in one patient (9.1%), and during the follow-up period, tumor recurrence occurred in one patient (9.1%).ConclusionThe expanded TLTA provides a feasible suprachiasm corridor to remove tumors extending into the third ventricle, especially for craniopharyngiomas. Sound understanding of the major strengths and limitations of this approach, as well as strategies for complication avoidance, is necessary for its safe and effective application.


Sign in / Sign up

Export Citation Format

Share Document